Traduction de «units in belgium » (Néerlandais → Français) :

TERMINOLOGIE

unit-dosis | gewone hoeveelheid van een geneesmiddel
?

TRADUCTIONS EN CONTEXTE

Guy Coertjens, Business Unit Manager BIS Industrial Services Danny Smet, Senior Ingenieur Persoonlijke Veiligheid en Arbeidshygiëne Fina Antwerp Olefins Christian Dierick, adviseur Agoria sector mechatronica Benoit Pinet, General Management Collaborator FIB Belgium Philip Knipscheer, directeur Gouda Vuurvast Belgium Marc Vogels, Civil Works BASF Antwerpen Werner Van der Steen, Managing Director Keramab Serge Kwasniewski, adviseur gezondheid essenscia Tom Van Weyenberg, Bedrijfsarts BASF Geert De Prez, adviseur veiligheid en gezondheid Agoria
Guy Coertjens, Business Unit Manager BIS Industrial Services Danny Smet, ingénieur en chef, Sécurité des personnes et hygiène au travail, Fina Antwerp Olefins Christian Dierick, conseiller Agoria, secteur mécatronique Benoit Pinet, General Management Collaborator FIB Belgium Philip Knipscheer, directeur de Gouda Vuurvast Belgium Marc Vogels, Civil Works BASF Anvers Werner Van der Steen, Managing Director Keramab Serge Kwasniewski, conseiller Santé, Essenscia Tom Van Weyenberg, médecin du travail BASF Geert De Prez, conseiller Sécurité et santé Agoria

Belgium 1995 24,0 36,3 12,7 2,9 France 1998 20,0 31,3 9,9 3,2 Netherlands 1999 11,0 15,2 7,1 2,1 Canada 1997 15,0 24,1 6,1 3,9 Denmark 1996 18,4 27,2 10,1 2,7 Finland 1998 28,4 45,8 11,7 3,9 Germany 1999 14,3 22,5 6,9 3,3 Italy 1997 8,4 13,4 3,8 3,5 Russian 1998 43,1 77,8 12,6 6,2 Federation Thailand 1994 5,6 8,0 3,3 2,4 United States 1998 13,9 23,2 5,3 4,4
Belgique 1995 24,0 36,3 12,7 2,9 France 1998 20,0 31,3 9,9 3,2 Pays-Bas 1999 11,0 15,2 7,1 2,1 Canada 1997 15,0 24,1 6,1 3,9 Danemark 1996 18,4 27,2 10,1 2,7 Finlande 1998 28,4 45,8 11,7 3,9 Allemagne 1999 14,3 22,5 6,9 3,3

Vaartdijk 112 B-1070 BRUSSEL Belgium Bussiness unit de Tihange Département " Amiante" rue Albert Legrand 2 B-4500 Tihange
Digue du Canal 112 B-1070 BRUXELLES Belgium Bussiness unit de Tihange Département " Amiante" rue Albert Legrand 2 B-4500 Tihange

However, the figures do clearly show that there is a considerable number of early phase trials. There are 7 units in Belgium actively undertaking phase I clinical trials and a number of early phase trials are being conducted in centres where there is expertise in specific clinical areas.
However, the figures do clearly show that there is a considerable number of early phase trials. There are 7 units in Belgium actively undertaking phase I clinical trials and a number of early phase trials are being conducted in centres where there is expertise in specific clinical areas.

Houder van de vergunning voor het in de handel brengen en fabrikant. Houder van de vergunning: Reckitt Benckiser Healthcare (Belgium) NV/SA, Researchdreef 20, B-1070 Brussel Fabrikant: Reckitt Benckiser Healthcare International Ltd, Nottingham Site, Thane Road, Nottingham NG90 2DB, United Kingdom
Titulaire de l’autorisation de mise sur le marché et fabricant Titulaire de l’autorisation de mise sur le marché : Reckitt Benckiser Healthcare (Belgium) NV/SA Allée de la Recherche 20 B-1070 Bruxelles Fabricant : Reckitt Benckiser Healthcare International Ltd Nottingham Site Thane Road, Nottingham NG90 2DB, United Kingdom Délivrance Médicament non soumis à prescription médicale.

The Foundation against Cancer unites the forces in the fight against cancer and is active in the whole of Belgium.
La Fondation contre le Cancer rassemble les forces dans la lutte contre le cancer, et est active dans toute la Belgique.

The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.
The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.